Cross-species prediction of TF binding remains a major challenge due to the rapid evolutionary turnover of individual TF binding sites, resulting in cross-species predictive performance being consistently worse than within-species performance. In this study, we first propose a novel Nucleotide-Level Deep Neural Network (NLDNN) to predict TF binding within or across species. NLDNN regards the task of TF binding prediction as a nucleotide-level regression task. Beyond predictive performance, we also assess model performance by locating potential TF binding regions, discriminating TF-specific single-nucleotide polymorphisms (SNPs), and identifying causal disease-associated SNPs. Then, we design a dual-path framework for adversarial training of NLDNN to further improve the cross-species prediction performance by pulling the domain space of human and mouse species closer.
No takes yet. Share an insight, caveat, or question.
Qinhu Zhang (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: